sur Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health Announces Investor Webcast on August 14, 2025
Jaguar Health, Inc. is set to conduct an investor webcast on August 14, 2025, at 8:30 a.m. Eastern, following the filing of its second-quarter financial results on Form 10-Q for the period ended June 30, 2025. The webcast aims to provide corporate updates and a thorough review of the financials.
The company's CEO, Lisa Conte, is scheduled to present on August 20, 2025, at the Emerging Growth Conference, focusing on near-term catalysts for growth. This presentation will be available through online registration, with a replay accessible on EmergingGrowth.com.
Jaguar Health, a pharmaceutical company, develops plant-based medications for gastrointestinal ailments. Their portfolio includes the FDA-approved Mytesi®, addressing noninfectious diarrhea in HIV/AIDS patients under antiretroviral therapy.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Jaguar Health, Inc.